Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Milk Polar Lipid-Rich Dairy Powder is a bioactive food component and nutraceutical formulation enriched with lipids derived from the milk fat globule membrane (MFGM). The active components include a variety of phospholipids and sphingolipids, such as sphingomyelin, phosphatidylcholine, and phosphatidylethanolamine. Developed by researchers at the University of Connecticut, this intervention is primarily investigated for its potential to improve cardiometabolic risk factors in adults with dyslipidemia and abdominal obesity. Its mechanism of action involves the modulation of lipid metabolism pathways to reduce atherogenic lipoprotein cholesterol, the alteration of gut microbiota composition, and the attenuation of systemic inflammatory pathways. Clinical research suggests that daily consumption can influence lipoprotein metabolism and improve the overall lipid profile in at-risk populations.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Milk Polar Lipid-Rich Dairy Powder.